GDF9 Antikörper (N-Term)
Kurzübersicht für GDF9 Antikörper (N-Term) (ABIN952487)
Target
Alle GDF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 87-117, N-Term
-
Spezifität
- This antibody recognizes Human GDF9 (N-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 87-117 amino acids from the N-terminal region of Human GDF9
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GDF9 (Growth Differentiation Factor 9 (GDF9))
-
Andere Bezeichnung
- GDF9
-
Hintergrund
- Growth factors synthesized by ovarian somatic cells directly affect oocyte growth and function. Growth differentiation factor-9 (GDF9) is expressed in oocytes and is thought to be required for ovarian folliculogenesis. GDF9 is a member of the transforming growth factor-beta superfamily.Synonyms: GDF-9, Growth/differentiation factor 9
-
Molekulargewicht
- 51444 Da
-
Gen-ID
- 2661
-
NCBI Accession
- NP_005251
Target
-